{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-026054","form_type":"8-K","ticker":"ENVB","cik":"0000890821","company_name":"Enveric Biosciences, Inc.","filed_at":"2025-08-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.612641+00:00","generated_at":"2026-05-17T09:22:04.042045+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Enveric Biosciences files 8-K for investor presentation; no specific facts in filing","bullets":["Management will release a Q3 2025 investor presentation on the company's website on or about Aug 29, 2025.","Presentation may be used with investors, analysts, lenders, and business partners.","No financial or operational details from the presentation are included in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-026054","json":"https://secwatch.observer/filing/0001641172-25-026054.json","markdown":"https://secwatch.observer/filing/0001641172-25-026054.md","text":"https://secwatch.observer/filing/0001641172-25-026054.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/890821/000164117225026054/0001641172-25-026054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/890821/000164117225026054/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:22:04.042045+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}